| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sex Characteristics | 36 | 2021 | 2585 | 5.510 |
Why?
|
| Schizophrenia | 95 | 2023 | 6874 | 3.620 |
Why?
|
| Depressive Disorder, Major | 20 | 2021 | 4628 | 2.890 |
Why?
|
| Prenatal Exposure Delayed Effects | 18 | 2023 | 2407 | 2.630 |
Why?
|
| Psychotic Disorders | 24 | 2023 | 3040 | 2.220 |
Why?
|
| Growth Differentiation Factors | 5 | 2023 | 98 | 1.830 |
Why?
|
| Stress, Psychological | 15 | 2021 | 4229 | 1.740 |
Why?
|
| Schizophrenic Psychology | 34 | 2016 | 1677 | 1.570 |
Why?
|
| Hypothalamus | 10 | 2021 | 1063 | 1.520 |
Why?
|
| Brain | 53 | 2024 | 26343 | 1.520 |
Why?
|
| Hypothalamo-Hypophyseal System | 8 | 2018 | 703 | 1.480 |
Why?
|
| Sex Factors | 35 | 2021 | 10392 | 1.470 |
Why?
|
| Affective Disorders, Psychotic | 7 | 2017 | 191 | 1.380 |
Why?
|
| Menopause | 6 | 2024 | 1621 | 1.330 |
Why?
|
| Prefrontal Cortex | 16 | 2019 | 2146 | 1.300 |
Why?
|
| Bone Morphogenetic Proteins | 6 | 2023 | 838 | 1.240 |
Why?
|
| Pituitary-Adrenal System | 7 | 2018 | 553 | 1.210 |
Why?
|
| Magnetic Resonance Imaging | 64 | 2021 | 35342 | 1.090 |
Why?
|
| Vagus Nerve Stimulation | 4 | 2021 | 199 | 1.060 |
Why?
|
| Estradiol | 8 | 2019 | 2021 | 1.060 |
Why?
|
| Hydrocortisone | 8 | 2023 | 1825 | 1.030 |
Why?
|
| Amygdala | 11 | 2020 | 1305 | 1.030 |
Why?
|
| Memory, Short-Term | 10 | 2019 | 972 | 1.020 |
Why?
|
| Neuropsychological Tests | 36 | 2022 | 6974 | 0.950 |
Why?
|
| Brain Mapping | 28 | 2021 | 6669 | 0.950 |
Why?
|
| Androgens | 3 | 2020 | 1271 | 0.920 |
Why?
|
| Gene Deletion | 3 | 2019 | 2751 | 0.900 |
Why?
|
| Anorexia Nervosa | 5 | 2015 | 1286 | 0.870 |
Why?
|
| NFATC Transcription Factors | 2 | 2015 | 380 | 0.870 |
Why?
|
| Affect | 6 | 2017 | 1473 | 0.850 |
Why?
|
| Verbal Learning | 5 | 2017 | 466 | 0.840 |
Why?
|
| Memory | 6 | 2019 | 2163 | 0.830 |
Why?
|
| Hippocampus | 13 | 2020 | 3661 | 0.830 |
Why?
|
| Satiation | 2 | 2012 | 80 | 0.820 |
Why?
|
| Aging | 8 | 2024 | 8626 | 0.810 |
Why?
|
| Pregnancy Trimester, Third | 3 | 2020 | 571 | 0.790 |
Why?
|
| Cerebral Cortex | 9 | 2023 | 5705 | 0.770 |
Why?
|
| Hunger | 3 | 2013 | 198 | 0.770 |
Why?
|
| Female | 173 | 2024 | 379592 | 0.750 |
Why?
|
| Progesterone | 5 | 2014 | 773 | 0.730 |
Why?
|
| Cytokines | 5 | 2021 | 7317 | 0.730 |
Why?
|
| Dehydroepiandrosterone Sulfate | 1 | 2019 | 238 | 0.650 |
Why?
|
| Male | 151 | 2024 | 349538 | 0.640 |
Why?
|
| Skin | 3 | 2019 | 4353 | 0.630 |
Why?
|
| Satellite Cells, Skeletal Muscle | 1 | 2019 | 124 | 0.620 |
Why?
|
| Hair Follicle | 3 | 2015 | 209 | 0.620 |
Why?
|
| Reward | 7 | 2021 | 940 | 0.610 |
Why?
|
| Schizophrenic Language | 3 | 2006 | 69 | 0.610 |
Why?
|
| Adult | 134 | 2023 | 213712 | 0.600 |
Why?
|
| Pregnancy Complications | 7 | 2016 | 2861 | 0.590 |
Why?
|
| Menstrual Cycle | 4 | 2010 | 551 | 0.580 |
Why?
|
| Fetal Hypoxia | 2 | 2011 | 29 | 0.580 |
Why?
|
| Bipolar Disorder | 9 | 2021 | 5024 | 0.570 |
Why?
|
| Dibenzothiazepines | 6 | 2003 | 104 | 0.570 |
Why?
|
| Pregnancy | 30 | 2023 | 29087 | 0.570 |
Why?
|
| Family Health | 5 | 2012 | 1282 | 0.560 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2018 | 455 | 0.560 |
Why?
|
| Ghrelin | 2 | 2018 | 266 | 0.560 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2019 | 604 | 0.530 |
Why?
|
| Antipsychotic Agents | 11 | 2015 | 3058 | 0.530 |
Why?
|
| Adult Children | 1 | 2016 | 99 | 0.530 |
Why?
|
| Practice Management, Dental | 3 | 2002 | 17 | 0.530 |
Why?
|
| Humans | 200 | 2024 | 742088 | 0.520 |
Why?
|
| Language Disorders | 2 | 2006 | 140 | 0.520 |
Why?
|
| Food Preferences | 2 | 2018 | 399 | 0.500 |
Why?
|
| Neural Pathways | 10 | 2019 | 2971 | 0.490 |
Why?
|
| Image Processing, Computer-Assisted | 23 | 2018 | 8925 | 0.490 |
Why?
|
| Dependovirus | 1 | 2019 | 706 | 0.470 |
Why?
|
| Genome | 2 | 2019 | 1803 | 0.470 |
Why?
|
| Genetic Predisposition to Disease | 17 | 2021 | 17400 | 0.470 |
Why?
|
| Cognition Disorders | 11 | 2017 | 4030 | 0.460 |
Why?
|
| Hypothalamic Hormones | 2 | 2013 | 147 | 0.450 |
Why?
|
| Hematopoiesis | 2 | 2019 | 2066 | 0.450 |
Why?
|
| New England | 8 | 2020 | 1021 | 0.450 |
Why?
|
| Pituitary Hormones | 2 | 2013 | 183 | 0.450 |
Why?
|
| Intelligence | 5 | 2018 | 920 | 0.450 |
Why?
|
| Calcineurin | 1 | 2014 | 226 | 0.450 |
Why?
|
| Prenatal Care | 1 | 2020 | 1088 | 0.440 |
Why?
|
| Hematopoietic Stem Cells | 3 | 2019 | 3381 | 0.430 |
Why?
|
| Extinction, Psychological | 3 | 2011 | 376 | 0.420 |
Why?
|
| Metabolic Diseases | 1 | 2018 | 657 | 0.400 |
Why?
|
| Lactation | 1 | 2014 | 412 | 0.400 |
Why?
|
| Data Interpretation, Statistical | 2 | 2018 | 2714 | 0.400 |
Why?
|
| Gyrus Cinguli | 7 | 2023 | 1088 | 0.390 |
Why?
|
| Prader-Willi Syndrome | 1 | 2011 | 79 | 0.390 |
Why?
|
| Cardiovascular Diseases | 4 | 2021 | 15108 | 0.380 |
Why?
|
| Multipotent Stem Cells | 1 | 2012 | 183 | 0.380 |
Why?
|
| Maternal Exposure | 2 | 2017 | 961 | 0.380 |
Why?
|
| Fetal Development | 2 | 2013 | 767 | 0.370 |
Why?
|
| Myasthenia Gravis | 3 | 2001 | 201 | 0.360 |
Why?
|
| Stress, Physiological | 2 | 2016 | 1402 | 0.360 |
Why?
|
| Young Adult | 41 | 2023 | 56350 | 0.360 |
Why?
|
| Men | 1 | 2010 | 63 | 0.350 |
Why?
|
| Psychiatric Status Rating Scales | 23 | 2016 | 6030 | 0.350 |
Why?
|
| Biomedical Research | 4 | 2021 | 3306 | 0.350 |
Why?
|
| Women | 2 | 2010 | 230 | 0.340 |
Why?
|
| Middle Aged | 71 | 2024 | 213127 | 0.340 |
Why?
|
| Appetite | 4 | 2018 | 243 | 0.340 |
Why?
|
| Nerve Fibers, Myelinated | 3 | 2013 | 960 | 0.330 |
Why?
|
| Evoked Potentials, Auditory | 3 | 2019 | 525 | 0.330 |
Why?
|
| Perinatal Care | 1 | 2011 | 227 | 0.330 |
Why?
|
| Myostatin | 2 | 2023 | 124 | 0.330 |
Why?
|
| Energy Intake | 3 | 2021 | 2147 | 0.330 |
Why?
|
| Stem Cell Niche | 1 | 2012 | 342 | 0.330 |
Why?
|
| Weight Gain | 2 | 2020 | 2282 | 0.330 |
Why?
|
| Motivation | 3 | 2015 | 1968 | 0.320 |
Why?
|
| Alleles | 1 | 2019 | 6931 | 0.320 |
Why?
|
| Conditioning, Classical | 2 | 2011 | 364 | 0.320 |
Why?
|
| Depression | 9 | 2021 | 7733 | 0.310 |
Why?
|
| Photic Stimulation | 6 | 2014 | 2027 | 0.310 |
Why?
|
| Memory Disorders | 5 | 2024 | 1183 | 0.310 |
Why?
|
| Case-Control Studies | 18 | 2019 | 21719 | 0.310 |
Why?
|
| Nerve Net | 4 | 2016 | 2174 | 0.300 |
Why?
|
| gamma-Aminobutyric Acid | 3 | 2023 | 1123 | 0.300 |
Why?
|
| Hormones | 2 | 2014 | 884 | 0.300 |
Why?
|
| Inflammation Mediators | 1 | 2016 | 1889 | 0.300 |
Why?
|
| Fear | 3 | 2011 | 1436 | 0.290 |
Why?
|
| Autonomic Nervous System | 1 | 2012 | 671 | 0.290 |
Why?
|
| Child Development | 5 | 2020 | 2222 | 0.290 |
Why?
|
| Acoustic Stimulation | 3 | 2012 | 1216 | 0.280 |
Why?
|
| Frontal Lobe | 7 | 2019 | 1407 | 0.280 |
Why?
|
| Mental Recall | 5 | 2017 | 1205 | 0.270 |
Why?
|
| Oxygen | 9 | 2017 | 4169 | 0.270 |
Why?
|
| Corpus Callosum | 3 | 2016 | 737 | 0.270 |
Why?
|
| Obesity | 4 | 2021 | 12705 | 0.270 |
Why?
|
| Haloperidol | 4 | 2003 | 397 | 0.270 |
Why?
|
| Arousal | 4 | 2012 | 1165 | 0.270 |
Why?
|
| Postprandial Period | 5 | 2013 | 292 | 0.270 |
Why?
|
| Mothers | 5 | 2021 | 2163 | 0.260 |
Why?
|
| Stress Disorders, Traumatic | 1 | 2005 | 53 | 0.260 |
Why?
|
| Limbic System | 5 | 2019 | 426 | 0.260 |
Why?
|
| Pirenzepine | 2 | 2002 | 115 | 0.260 |
Why?
|
| Hypertension | 2 | 2022 | 8455 | 0.260 |
Why?
|
| Neurosecretory Systems | 1 | 2006 | 231 | 0.250 |
Why?
|
| Event-Related Potentials, P300 | 3 | 2014 | 150 | 0.250 |
Why?
|
| Alzheimer Disease | 3 | 2021 | 7988 | 0.250 |
Why?
|
| England | 2 | 2023 | 523 | 0.250 |
Why?
|
| Diffusion Tensor Imaging | 8 | 2019 | 2304 | 0.240 |
Why?
|
| Stem Cells | 2 | 2015 | 3563 | 0.240 |
Why?
|
| Reproduction | 2 | 2019 | 668 | 0.240 |
Why?
|
| Schizotypal Personality Disorder | 4 | 2003 | 288 | 0.240 |
Why?
|
| Brain Stem | 2 | 2020 | 844 | 0.240 |
Why?
|
| Image Interpretation, Computer-Assisted | 4 | 2016 | 3328 | 0.240 |
Why?
|
| Cognition | 6 | 2022 | 6722 | 0.240 |
Why?
|
| Weight Loss | 3 | 2021 | 2604 | 0.240 |
Why?
|
| Interpersonal Relations | 4 | 2013 | 1423 | 0.230 |
Why?
|
| Anxiety | 7 | 2021 | 4279 | 0.230 |
Why?
|
| Temporal Lobe | 6 | 2014 | 1669 | 0.230 |
Why?
|
| Attention | 8 | 2014 | 2396 | 0.230 |
Why?
|
| Risk Factors | 22 | 2023 | 72145 | 0.230 |
Why?
|
| Corpus Striatum | 3 | 2014 | 1220 | 0.230 |
Why?
|
| Comorbidity | 5 | 2021 | 10372 | 0.230 |
Why?
|
| Research Design | 2 | 2018 | 5979 | 0.230 |
Why?
|
| Feeding Behavior | 5 | 2021 | 3187 | 0.220 |
Why?
|
| Gonads | 2 | 2016 | 107 | 0.210 |
Why?
|
| Adolescent | 39 | 2023 | 85649 | 0.210 |
Why?
|
| Women's Health | 3 | 2020 | 2034 | 0.210 |
Why?
|
| Functional Laterality | 7 | 2006 | 2290 | 0.200 |
Why?
|
| Psychomotor Performance | 4 | 2014 | 1895 | 0.200 |
Why?
|
| Cell Differentiation | 1 | 2019 | 11470 | 0.200 |
Why?
|
| Dental Enamel | 1 | 2021 | 64 | 0.200 |
Why?
|
| Rhode Island | 3 | 2011 | 347 | 0.200 |
Why?
|
| Sulfurtransferases | 1 | 2021 | 17 | 0.200 |
Why?
|
| Intelligence Tests | 4 | 2015 | 505 | 0.200 |
Why?
|
| Executive Function | 2 | 2022 | 1362 | 0.190 |
Why?
|
| Transcutaneous Electric Nerve Stimulation | 2 | 2020 | 161 | 0.190 |
Why?
|
| Parahippocampal Gyrus | 2 | 2016 | 116 | 0.190 |
Why?
|
| Life Change Events | 1 | 2005 | 937 | 0.190 |
Why?
|
| Animals | 23 | 2023 | 168561 | 0.180 |
Why?
|
| Parents | 2 | 2013 | 3387 | 0.180 |
Why?
|
| Keratinocytes | 2 | 2015 | 797 | 0.180 |
Why?
|
| Statistics as Topic | 5 | 2016 | 2372 | 0.180 |
Why?
|
| Men's Health | 1 | 2020 | 73 | 0.180 |
Why?
|
| Vagus Nerve | 2 | 2020 | 437 | 0.180 |
Why?
|
| Delusions | 4 | 2015 | 300 | 0.180 |
Why?
|
| Cohort Studies | 18 | 2020 | 40450 | 0.180 |
Why?
|
| Mood Disorders | 1 | 2006 | 1106 | 0.170 |
Why?
|
| Cholinergic Antagonists | 1 | 2000 | 165 | 0.170 |
Why?
|
| Gender Identity | 3 | 2018 | 681 | 0.170 |
Why?
|
| Dental Staff | 1 | 1999 | 14 | 0.170 |
Why?
|
| Bone Development | 1 | 2023 | 483 | 0.170 |
Why?
|
| Mice, Inbred mdx | 1 | 2019 | 90 | 0.170 |
Why?
|
| Endothelial Cells | 2 | 2023 | 3455 | 0.170 |
Why?
|
| Longitudinal Studies | 9 | 2021 | 13921 | 0.170 |
Why?
|
| Child Behavior Disorders | 2 | 2017 | 807 | 0.170 |
Why?
|
| Task Performance and Analysis | 5 | 2016 | 780 | 0.170 |
Why?
|
| Postmenopause | 2 | 2018 | 2461 | 0.170 |
Why?
|
| Risk | 10 | 2019 | 9679 | 0.160 |
Why?
|
| Reminder Systems | 1 | 2002 | 370 | 0.160 |
Why?
|
| Oxytocin | 2 | 2013 | 395 | 0.160 |
Why?
|
| Employee Performance Appraisal | 1 | 1999 | 87 | 0.160 |
Why?
|
| Diet, Carbohydrate-Restricted | 1 | 2021 | 257 | 0.160 |
Why?
|
| Skin Neoplasms | 2 | 2015 | 5662 | 0.160 |
Why?
|
| Child of Impaired Parents | 2 | 2013 | 455 | 0.160 |
Why?
|
| Appointments and Schedules | 1 | 2002 | 414 | 0.160 |
Why?
|
| Hyperphagia | 1 | 2018 | 136 | 0.160 |
Why?
|
| Tryptophan | 1 | 2019 | 478 | 0.150 |
Why?
|
| Social Environment | 4 | 1992 | 1023 | 0.150 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 1 | 2021 | 664 | 0.150 |
Why?
|
| Signal Transduction | 5 | 2014 | 23387 | 0.150 |
Why?
|
| Brain Chemistry | 1 | 2001 | 981 | 0.150 |
Why?
|
| Age Factors | 13 | 2019 | 18355 | 0.150 |
Why?
|
| Prolactin | 2 | 2014 | 669 | 0.150 |
Why?
|
| Women's Health Services | 1 | 2017 | 93 | 0.150 |
Why?
|
| Mice, Knockout | 5 | 2019 | 14554 | 0.150 |
Why?
|
| Mental Disorders | 6 | 2020 | 6587 | 0.140 |
Why?
|
| Heart Rate | 3 | 2020 | 4091 | 0.140 |
Why?
|
| Military Personnel | 1 | 2005 | 1132 | 0.140 |
Why?
|
| Adrenal Glands | 1 | 2019 | 547 | 0.140 |
Why?
|
| Child | 21 | 2021 | 77478 | 0.140 |
Why?
|
| Integrases | 1 | 2019 | 533 | 0.140 |
Why?
|
| Huntington Disease | 1 | 2003 | 1111 | 0.140 |
Why?
|
| Gonadotropins | 1 | 2017 | 241 | 0.140 |
Why?
|
| Factor Analysis, Statistical | 3 | 2016 | 975 | 0.140 |
Why?
|
| Language Tests | 2 | 2006 | 200 | 0.140 |
Why?
|
| Cytochrome P-450 CYP2E1 | 1 | 2015 | 36 | 0.140 |
Why?
|
| 9,10-Dimethyl-1,2-benzanthracene | 1 | 2015 | 62 | 0.140 |
Why?
|
| Pregnancy Complications, Infectious | 2 | 2019 | 2026 | 0.130 |
Why?
|
| Food | 2 | 2018 | 769 | 0.130 |
Why?
|
| Lateral Ventricles | 1 | 2016 | 145 | 0.130 |
Why?
|
| Caudate Nucleus | 2 | 2016 | 393 | 0.130 |
Why?
|
| Dominance, Cerebral | 4 | 2006 | 635 | 0.130 |
Why?
|
| Genes, Reporter | 1 | 2019 | 1547 | 0.130 |
Why?
|
| Maternal Age | 1 | 2018 | 802 | 0.130 |
Why?
|
| Myelin Sheath | 1 | 2019 | 652 | 0.130 |
Why?
|
| Psychological Tests | 2 | 2017 | 648 | 0.130 |
Why?
|
| Socioeconomic Factors | 5 | 2018 | 7770 | 0.130 |
Why?
|
| Phonetics | 2 | 2006 | 206 | 0.130 |
Why?
|
| Homozygote | 1 | 2019 | 1777 | 0.130 |
Why?
|
| Interleukin-8 | 1 | 2018 | 689 | 0.130 |
Why?
|
| Gastrectomy | 1 | 2019 | 652 | 0.130 |
Why?
|
| Respiratory Mechanics | 1 | 2019 | 681 | 0.130 |
Why?
|
| Mice | 10 | 2023 | 81045 | 0.130 |
Why?
|
| Myeloid Cells | 1 | 2019 | 804 | 0.130 |
Why?
|
| Analysis of Variance | 10 | 2016 | 6365 | 0.120 |
Why?
|
| Prospective Studies | 11 | 2023 | 53187 | 0.120 |
Why?
|
| Rest | 1 | 2019 | 900 | 0.120 |
Why?
|
| Adrenocorticotropic Hormone | 2 | 2013 | 648 | 0.120 |
Why?
|
| Receptors, Prolactin | 1 | 2014 | 17 | 0.120 |
Why?
|
| Papilloma | 1 | 2015 | 148 | 0.120 |
Why?
|
| Premenopause | 1 | 2018 | 1033 | 0.120 |
Why?
|
| Acylation | 1 | 2014 | 107 | 0.120 |
Why?
|
| Social Adjustment | 4 | 2010 | 630 | 0.120 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2015 | 821 | 0.120 |
Why?
|
| Interleukin-10 | 2 | 2018 | 1200 | 0.120 |
Why?
|
| Mice, Inbred C57BL | 4 | 2019 | 21821 | 0.120 |
Why?
|
| Cross-Sectional Studies | 9 | 2018 | 24913 | 0.120 |
Why?
|
| Health Maintenance Organizations | 1 | 1997 | 642 | 0.120 |
Why?
|
| Nerve Degeneration | 2 | 2012 | 748 | 0.120 |
Why?
|
| Parietal Lobe | 3 | 2013 | 837 | 0.120 |
Why?
|
| Green Fluorescent Proteins | 1 | 2019 | 2088 | 0.120 |
Why?
|
| Glutamic Acid | 1 | 2019 | 1167 | 0.120 |
Why?
|
| Gene Transfer Techniques | 1 | 2019 | 1224 | 0.120 |
Why?
|
| Genetic Engineering | 1 | 2019 | 952 | 0.120 |
Why?
|
| Family | 5 | 2007 | 3144 | 0.120 |
Why?
|
| Reference Values | 8 | 2006 | 4982 | 0.110 |
Why?
|
| Fathers | 3 | 2011 | 357 | 0.110 |
Why?
|
| STAT5 Transcription Factor | 1 | 2014 | 259 | 0.110 |
Why?
|
| Phenotype | 9 | 2021 | 16331 | 0.110 |
Why?
|
| Child, Preschool | 11 | 2020 | 40955 | 0.110 |
Why?
|
| Multifactorial Inheritance | 1 | 2021 | 1190 | 0.110 |
Why?
|
| Thalamus | 4 | 2007 | 1023 | 0.110 |
Why?
|
| Respiration | 1 | 2020 | 1645 | 0.110 |
Why?
|
| Infant, Newborn | 5 | 2020 | 25575 | 0.110 |
Why?
|
| Sex Chromosomes | 1 | 2013 | 105 | 0.110 |
Why?
|
| Primary Prevention | 1 | 2021 | 1166 | 0.110 |
Why?
|
| Sex Differentiation | 2 | 2006 | 73 | 0.110 |
Why?
|
| Autonomic Nervous System Diseases | 1 | 2015 | 257 | 0.110 |
Why?
|
| Carcinogens | 1 | 2015 | 466 | 0.110 |
Why?
|
| Neuroprotective Agents | 1 | 2019 | 941 | 0.110 |
Why?
|
| Anorexia | 1 | 2013 | 159 | 0.110 |
Why?
|
| Janus Kinases | 1 | 2014 | 244 | 0.110 |
Why?
|
| Birth Injuries | 3 | 2015 | 148 | 0.110 |
Why?
|
| Affective Symptoms | 1 | 1995 | 407 | 0.110 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2019 | 851 | 0.110 |
Why?
|
| Semantics | 2 | 2006 | 584 | 0.110 |
Why?
|
| Electroencephalography | 5 | 2014 | 6142 | 0.110 |
Why?
|
| Ligands | 1 | 2019 | 3293 | 0.110 |
Why?
|
| Parvalbumins | 1 | 2014 | 246 | 0.110 |
Why?
|
| Anisotropy | 5 | 2015 | 1265 | 0.110 |
Why?
|
| Neurologic Examination | 1 | 2015 | 931 | 0.110 |
Why?
|
| Pilot Projects | 6 | 2018 | 8297 | 0.110 |
Why?
|
| Birth Weight | 1 | 2020 | 2068 | 0.100 |
Why?
|
| Testosterone | 2 | 2014 | 2401 | 0.100 |
Why?
|
| Psychophysics | 3 | 2011 | 309 | 0.100 |
Why?
|
| Infant | 7 | 2017 | 35070 | 0.100 |
Why?
|
| Steroids | 1 | 2017 | 931 | 0.100 |
Why?
|
| Genome-Wide Association Study | 2 | 2021 | 12220 | 0.100 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2021 | 15494 | 0.100 |
Why?
|
| Evoked Potentials, Visual | 1 | 2014 | 427 | 0.100 |
Why?
|
| Bayes Theorem | 2 | 2018 | 2303 | 0.100 |
Why?
|
| Pyramidal Cells | 1 | 2014 | 363 | 0.100 |
Why?
|
| Learning | 2 | 2017 | 1705 | 0.100 |
Why?
|
| Bariatric Surgery | 2 | 2019 | 940 | 0.100 |
Why?
|
| Inheritance Patterns | 1 | 2013 | 340 | 0.100 |
Why?
|
| Cyclosporine | 1 | 2014 | 784 | 0.100 |
Why?
|
| Skin Physiological Phenomena | 1 | 2012 | 180 | 0.100 |
Why?
|
| Publishing | 1 | 1998 | 833 | 0.100 |
Why?
|
| Muscle Cells | 1 | 2012 | 196 | 0.100 |
Why?
|
| Bacterial Infections | 1 | 2019 | 1389 | 0.100 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2014 | 504 | 0.100 |
Why?
|
| Environment | 2 | 2010 | 1115 | 0.100 |
Why?
|
| Glycemic Index | 1 | 2013 | 395 | 0.090 |
Why?
|
| Severity of Illness Index | 9 | 2019 | 15530 | 0.090 |
Why?
|
| Residential Facilities | 1 | 1990 | 43 | 0.090 |
Why?
|
| Myocytes, Cardiac | 1 | 2019 | 1636 | 0.090 |
Why?
|
| Follow-Up Studies | 15 | 2019 | 39004 | 0.090 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2020 | 4414 | 0.090 |
Why?
|
| Genetic Loci | 1 | 2019 | 2572 | 0.090 |
Why?
|
| Leukoencephalopathies | 1 | 2013 | 238 | 0.090 |
Why?
|
| Regional Blood Flow | 1 | 2013 | 1525 | 0.090 |
Why?
|
| Logistic Models | 3 | 2015 | 13403 | 0.090 |
Why?
|
| Paternal Age | 1 | 2009 | 84 | 0.090 |
Why?
|
| Caregivers | 1 | 2021 | 2074 | 0.080 |
Why?
|
| Virus Diseases | 1 | 2015 | 710 | 0.080 |
Why?
|
| Cerebellar Ataxia | 1 | 1990 | 145 | 0.080 |
Why?
|
| Obesity, Morbid | 1 | 2019 | 1204 | 0.080 |
Why?
|
| Aged | 23 | 2017 | 162944 | 0.080 |
Why?
|
| Prevalence | 3 | 2018 | 15194 | 0.080 |
Why?
|
| Melanocytes | 1 | 2012 | 515 | 0.080 |
Why?
|
| Statistics, Nonparametric | 3 | 2017 | 2885 | 0.080 |
Why?
|
| Cadherins | 1 | 2012 | 906 | 0.080 |
Why?
|
| Organ Size | 4 | 2018 | 2253 | 0.080 |
Why?
|
| Atrophy | 3 | 2003 | 1576 | 0.080 |
Why?
|
| Enzyme Activation | 1 | 2014 | 3701 | 0.080 |
Why?
|
| Incidence | 4 | 2018 | 20928 | 0.080 |
Why?
|
| Aminolevulinic Acid | 1 | 2008 | 142 | 0.080 |
Why?
|
| Housing | 2 | 1990 | 663 | 0.080 |
Why?
|
| Boston | 2 | 2011 | 9305 | 0.080 |
Why?
|
| Muscle, Skeletal | 1 | 2023 | 4933 | 0.080 |
Why?
|
| Attitude to Health | 2 | 2004 | 2051 | 0.070 |
Why?
|
| Academic Medical Centers | 1 | 2017 | 2749 | 0.070 |
Why?
|
| Cell Movement | 1 | 2019 | 5212 | 0.070 |
Why?
|
| Models, Statistical | 3 | 2018 | 5100 | 0.070 |
Why?
|
| Social Class | 1 | 2015 | 1995 | 0.070 |
Why?
|
| Social Support | 4 | 1990 | 2117 | 0.070 |
Why?
|
| Clozapine | 3 | 2002 | 498 | 0.070 |
Why?
|
| Ambulatory Care | 3 | 2006 | 2706 | 0.070 |
Why?
|
| Cerebrovascular Circulation | 1 | 2016 | 2732 | 0.070 |
Why?
|
| Cell Adhesion | 1 | 2012 | 3139 | 0.070 |
Why?
|
| Avoidance Learning | 2 | 2005 | 233 | 0.070 |
Why?
|
| Cells, Cultured | 2 | 2019 | 19223 | 0.070 |
Why?
|
| Brain Edema | 1 | 1990 | 617 | 0.070 |
Why?
|
| Linguistics | 1 | 2006 | 96 | 0.070 |
Why?
|
| DNA Damage | 1 | 2015 | 2423 | 0.070 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 3 | 2015 | 2736 | 0.060 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2009 | 780 | 0.060 |
Why?
|
| Nervous System Diseases | 1 | 2015 | 1617 | 0.060 |
Why?
|
| Adipocytes | 1 | 2012 | 1182 | 0.060 |
Why?
|
| Developmental Disabilities | 1 | 2013 | 1452 | 0.060 |
Why?
|
| Age of Onset | 4 | 2015 | 3266 | 0.060 |
Why?
|
| Perinatology | 1 | 2004 | 57 | 0.060 |
Why?
|
| Body Mass Index | 2 | 2020 | 12695 | 0.060 |
Why?
|
| Disease Progression | 3 | 2019 | 13256 | 0.060 |
Why?
|
| Delivery of Health Care | 2 | 2020 | 5304 | 0.060 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2019 | 3617 | 0.060 |
Why?
|
| Neurons | 3 | 2014 | 9325 | 0.060 |
Why?
|
| Estrogens | 1 | 2011 | 1562 | 0.060 |
Why?
|
| Emotions | 3 | 2021 | 2657 | 0.060 |
Why?
|
| Myelin Proteins | 2 | 1994 | 215 | 0.060 |
Why?
|
| Body Weight | 2 | 2012 | 4664 | 0.060 |
Why?
|
| Pattern Recognition, Automated | 1 | 2010 | 996 | 0.060 |
Why?
|
| Parabiosis | 1 | 2023 | 65 | 0.060 |
Why?
|
| Verbal Behavior | 2 | 2004 | 339 | 0.060 |
Why?
|
| Lead | 1 | 2008 | 854 | 0.060 |
Why?
|
| Dementia | 1 | 2017 | 2501 | 0.050 |
Why?
|
| Double-Blind Method | 6 | 1996 | 12017 | 0.050 |
Why?
|
| Tourette Syndrome | 2 | 1996 | 379 | 0.050 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2006 | 711 | 0.050 |
Why?
|
| Hostility | 1 | 2003 | 189 | 0.050 |
Why?
|
| Schizophrenia, Paranoid | 2 | 1994 | 104 | 0.050 |
Why?
|
| Peripheral Nervous System Diseases | 3 | 1997 | 700 | 0.050 |
Why?
|
| Tooth, Deciduous | 1 | 2021 | 74 | 0.050 |
Why?
|
| Linear Models | 3 | 2007 | 5948 | 0.050 |
Why?
|
| Gene Knockdown Techniques | 2 | 2019 | 1655 | 0.050 |
Why?
|
| Cocaine-Related Disorders | 1 | 2004 | 460 | 0.050 |
Why?
|
| Transforming Growth Factor beta | 2 | 2023 | 2006 | 0.050 |
Why?
|
| MicroRNAs | 2 | 2014 | 3731 | 0.050 |
Why?
|
| Nuclear Family | 2 | 2004 | 318 | 0.050 |
Why?
|
| Reproducibility of Results | 7 | 2020 | 19862 | 0.050 |
Why?
|
| Mental Fatigue | 1 | 2000 | 20 | 0.050 |
Why?
|
| Eating | 2 | 2021 | 1535 | 0.050 |
Why?
|
| Psychomotor Agitation | 1 | 2003 | 288 | 0.050 |
Why?
|
| Sex Distribution | 1 | 2006 | 2295 | 0.050 |
Why?
|
| Muscle Fatigue | 1 | 2000 | 82 | 0.050 |
Why?
|
| Receptors, Muscarinic | 1 | 2000 | 156 | 0.050 |
Why?
|
| Tegmentum Mesencephali | 1 | 1980 | 59 | 0.040 |
Why?
|
| Risperidone | 1 | 2002 | 383 | 0.040 |
Why?
|
| Multivariate Analysis | 3 | 2006 | 12242 | 0.040 |
Why?
|
| Patient Readmission | 4 | 1989 | 3111 | 0.040 |
Why?
|
| Chronic Disease | 8 | 2014 | 9144 | 0.040 |
Why?
|
| Quality of Life | 1 | 2001 | 12730 | 0.040 |
Why?
|
| Receptors, Cholinergic | 1 | 2000 | 238 | 0.040 |
Why?
|
| Gait | 2 | 2015 | 784 | 0.040 |
Why?
|
| Markov Chains | 2 | 2018 | 969 | 0.040 |
Why?
|
| Septal Nuclei | 1 | 1980 | 84 | 0.040 |
Why?
|
| Gene Expression Profiling | 2 | 2014 | 9410 | 0.040 |
Why?
|
| Benzodiazepines | 2 | 2002 | 1101 | 0.040 |
Why?
|
| Algorithms | 5 | 2018 | 13853 | 0.040 |
Why?
|
| Probability | 3 | 2011 | 2502 | 0.040 |
Why?
|
| Respiratory Rate | 1 | 2020 | 162 | 0.040 |
Why?
|
| Personnel Management | 1 | 1999 | 55 | 0.040 |
Why?
|
| Acute Disease | 3 | 2016 | 7141 | 0.040 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2003 | 4029 | 0.040 |
Why?
|
| Models, Biological | 2 | 2012 | 9581 | 0.040 |
Why?
|
| Time Factors | 3 | 2012 | 40054 | 0.040 |
Why?
|
| Retrospective Studies | 12 | 2018 | 77098 | 0.040 |
Why?
|
| Blood Glucose | 1 | 2013 | 6249 | 0.040 |
Why?
|
| Efficiency | 1 | 2002 | 462 | 0.040 |
Why?
|
| Germany | 1 | 2020 | 860 | 0.040 |
Why?
|
| Auditory Perception | 2 | 2004 | 568 | 0.040 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 2 | 2007 | 3649 | 0.040 |
Why?
|
| Volition | 1 | 1998 | 63 | 0.040 |
Why?
|
| Inflammation | 1 | 2018 | 10578 | 0.040 |
Why?
|
| Migraine Disorders | 1 | 1990 | 1620 | 0.040 |
Why?
|
| Treatment Outcome | 6 | 2019 | 62966 | 0.040 |
Why?
|
| Psychometrics | 5 | 2010 | 2999 | 0.040 |
Why?
|
| Sulfoglycosphingolipids | 1 | 1997 | 19 | 0.040 |
Why?
|
| Myosin Heavy Chains | 1 | 2019 | 414 | 0.040 |
Why?
|
| Occipital Lobe | 1 | 1999 | 380 | 0.040 |
Why?
|
| Nucleus Accumbens | 1 | 1980 | 366 | 0.040 |
Why?
|
| Apomorphine | 2 | 1993 | 150 | 0.040 |
Why?
|
| Epigenesis, Genetic | 1 | 2010 | 3639 | 0.040 |
Why?
|
| Concept Formation | 1 | 1998 | 158 | 0.040 |
Why?
|
| Odds Ratio | 4 | 2015 | 9846 | 0.040 |
Why?
|
| Vocabulary | 1 | 1997 | 167 | 0.040 |
Why?
|
| Substance-Related Disorders | 2 | 2010 | 4250 | 0.040 |
Why?
|
| Amino Acids | 1 | 2023 | 1727 | 0.040 |
Why?
|
| Polychlorinated Biphenyls | 1 | 2018 | 245 | 0.040 |
Why?
|
| Dietary Carbohydrates | 1 | 2021 | 904 | 0.030 |
Why?
|
| Antibodies | 2 | 1994 | 2459 | 0.030 |
Why?
|
| Muscle Tonus | 1 | 2015 | 81 | 0.030 |
Why?
|
| Immunoglobulin M | 3 | 1997 | 1538 | 0.030 |
Why?
|
| Endophenotypes | 1 | 2017 | 250 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2014 | 12071 | 0.030 |
Why?
|
| Discrimination Learning | 1 | 1997 | 280 | 0.030 |
Why?
|
| Smell | 1 | 1997 | 243 | 0.030 |
Why?
|
| Infant, Low Birth Weight | 1 | 2000 | 850 | 0.030 |
Why?
|
| Vasomotor System | 1 | 2015 | 209 | 0.030 |
Why?
|
| Seasons | 2 | 1992 | 1492 | 0.030 |
Why?
|
| Mutation | 1 | 2019 | 29717 | 0.030 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2018 | 732 | 0.030 |
Why?
|
| Aggression | 1 | 1980 | 753 | 0.030 |
Why?
|
| Adaptation, Psychological | 1 | 2005 | 2575 | 0.030 |
Why?
|
| Receptors, Androgen | 1 | 2001 | 1057 | 0.030 |
Why?
|
| Horses | 1 | 2015 | 304 | 0.030 |
Why?
|
| Fertility | 1 | 2019 | 770 | 0.030 |
Why?
|
| Organ Specificity | 1 | 2019 | 2003 | 0.030 |
Why?
|
| Demyelinating Diseases | 1 | 1997 | 363 | 0.030 |
Why?
|
| Community Mental Health Services | 2 | 1990 | 386 | 0.030 |
Why?
|
| Receptors, Serotonin | 1 | 1995 | 210 | 0.030 |
Why?
|
| Naloxone | 1 | 1977 | 367 | 0.030 |
Why?
|
| Rats | 4 | 2015 | 24265 | 0.030 |
Why?
|
| Predictive Value of Tests | 3 | 2015 | 15056 | 0.030 |
Why?
|
| Attitude of Health Personnel | 1 | 1988 | 3839 | 0.030 |
Why?
|
| Regression Analysis | 2 | 2001 | 6452 | 0.030 |
Why?
|
| Monte Carlo Method | 1 | 2018 | 1254 | 0.030 |
Why?
|
| Brief Psychiatric Rating Scale | 1 | 2013 | 108 | 0.030 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 2 | 2013 | 1953 | 0.030 |
Why?
|
| Receptors, Estrogen | 1 | 2001 | 2186 | 0.030 |
Why?
|
| Nervous System Physiological Phenomena | 1 | 2013 | 117 | 0.030 |
Why?
|
| Sheep | 1 | 2015 | 1437 | 0.030 |
Why?
|
| Interview, Psychological | 2 | 2014 | 812 | 0.030 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2014 | 524 | 0.030 |
Why?
|
| Hallucinations | 1 | 2015 | 360 | 0.030 |
Why?
|
| Intercellular Junctions | 1 | 2012 | 203 | 0.030 |
Why?
|
| Interleukin-1beta | 1 | 2018 | 972 | 0.030 |
Why?
|
| Attitude | 2 | 1988 | 772 | 0.030 |
Why?
|
| Lipopolysaccharides | 1 | 2019 | 2211 | 0.030 |
Why?
|
| Biophysical Phenomena | 1 | 2012 | 327 | 0.030 |
Why?
|
| Metagenome | 1 | 2015 | 417 | 0.030 |
Why?
|
| Visual Perception | 1 | 2000 | 1417 | 0.030 |
Why?
|
| Microelectrodes | 1 | 1993 | 303 | 0.030 |
Why?
|
| Amphetamine | 1 | 1993 | 225 | 0.030 |
Why?
|
| Ventricular Remodeling | 1 | 2019 | 1224 | 0.030 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2019 | 1538 | 0.020 |
Why?
|
| Managed Care Programs | 1 | 1997 | 949 | 0.020 |
Why?
|
| Dinoprostone | 1 | 2014 | 600 | 0.020 |
Why?
|
| Movement Disorders | 1 | 1994 | 444 | 0.020 |
Why?
|
| Substantia Nigra | 1 | 1993 | 353 | 0.020 |
Why?
|
| Receptor, Notch1 | 1 | 2014 | 502 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2011 | 8300 | 0.020 |
Why?
|
| Propionates | 1 | 2011 | 168 | 0.020 |
Why?
|
| Culture Media | 1 | 2012 | 902 | 0.020 |
Why?
|
| Dopamine | 2 | 1993 | 1589 | 0.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2020 | 3760 | 0.020 |
Why?
|
| Normal Distribution | 1 | 2011 | 280 | 0.020 |
Why?
|
| Wnt Proteins | 1 | 2014 | 721 | 0.020 |
Why?
|
| Software | 2 | 2016 | 4434 | 0.020 |
Why?
|
| Gene Knockout Techniques | 1 | 2012 | 808 | 0.020 |
Why?
|
| Electrophysiology | 1 | 1993 | 1309 | 0.020 |
Why?
|
| United States | 4 | 2015 | 69693 | 0.020 |
Why?
|
| Environmental Pollutants | 1 | 2018 | 1180 | 0.020 |
Why?
|
| Personality Development | 1 | 1990 | 245 | 0.020 |
Why?
|
| Faculty, Medical | 1 | 2017 | 1182 | 0.020 |
Why?
|
| Personality Inventory | 1 | 2012 | 1026 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2013 | 1653 | 0.020 |
Why?
|
| Diffusion | 1 | 2011 | 832 | 0.020 |
Why?
|
| Cytoskeleton | 1 | 2014 | 1185 | 0.020 |
Why?
|
| Depressive Disorder | 2 | 1993 | 3748 | 0.020 |
Why?
|
| Internal-External Control | 1 | 2010 | 363 | 0.020 |
Why?
|
| Autoantibodies | 1 | 1997 | 2036 | 0.020 |
Why?
|
| Anthropometry | 1 | 2013 | 1350 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2011 | 575 | 0.020 |
Why?
|
| Father-Child Relations | 1 | 1988 | 48 | 0.020 |
Why?
|
| Social Behavior | 1 | 2015 | 1128 | 0.020 |
Why?
|
| Delivery, Obstetric | 1 | 2015 | 904 | 0.020 |
Why?
|
| Electric Stimulation | 2 | 2006 | 1770 | 0.020 |
Why?
|
| DNA, Viral | 1 | 2015 | 2224 | 0.020 |
Why?
|
| Personality Assessment | 1 | 2010 | 643 | 0.020 |
Why?
|
| Disease Susceptibility | 1 | 2015 | 1780 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2018 | 3199 | 0.020 |
Why?
|
| Aftercare | 2 | 1985 | 860 | 0.020 |
Why?
|
| Immunity, Innate | 1 | 2019 | 2956 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 1996 | 10943 | 0.020 |
Why?
|
| Periodicals as Topic | 1 | 1998 | 1431 | 0.020 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2012 | 541 | 0.020 |
Why?
|
| Phenols | 1 | 2011 | 501 | 0.020 |
Why?
|
| History, 21st Century | 1 | 2013 | 1533 | 0.020 |
Why?
|
| Ventricular Function, Left | 1 | 2019 | 3656 | 0.020 |
Why?
|
| Occupations | 1 | 2009 | 517 | 0.020 |
Why?
|
| Extracellular Matrix | 1 | 2014 | 1740 | 0.020 |
Why?
|
| Nitriles | 1 | 2011 | 952 | 0.020 |
Why?
|
| Fasting | 1 | 2012 | 1589 | 0.020 |
Why?
|
| Aged, 80 and over | 3 | 2017 | 57683 | 0.020 |
Why?
|
| Personnel, Hospital | 1 | 1988 | 283 | 0.020 |
Why?
|
| Risk Assessment | 4 | 2000 | 23320 | 0.020 |
Why?
|
| Receptors, Cell Surface | 1 | 1995 | 2867 | 0.020 |
Why?
|
| Random Allocation | 1 | 1990 | 2425 | 0.020 |
Why?
|
| History, 20th Century | 1 | 2013 | 2739 | 0.020 |
Why?
|
| Motor Activity | 1 | 2015 | 2714 | 0.020 |
Why?
|
| Electrocardiography | 1 | 2019 | 6440 | 0.020 |
Why?
|
| Gadolinium | 1 | 1990 | 951 | 0.020 |
Why?
|
| Action Potentials | 1 | 1993 | 1814 | 0.020 |
Why?
|
| Obsessive-Compulsive Disorder | 1 | 1994 | 1442 | 0.020 |
Why?
|
| Family Characteristics | 1 | 1990 | 999 | 0.020 |
Why?
|
| Actuarial Analysis | 1 | 1985 | 377 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2018 | 6191 | 0.020 |
Why?
|
| Communication | 1 | 1999 | 3728 | 0.020 |
Why?
|
| Proportional Hazards Models | 2 | 2006 | 12344 | 0.020 |
Why?
|
| Galvanic Skin Response | 1 | 2006 | 349 | 0.020 |
Why?
|
| Mother-Child Relations | 1 | 1988 | 481 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2020 | 8541 | 0.020 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2013 | 1847 | 0.020 |
Why?
|
| Myelin-Associated Glycoprotein | 2 | 1994 | 113 | 0.020 |
Why?
|
| Prognosis | 2 | 2019 | 29010 | 0.020 |
Why?
|
| Research Support as Topic | 1 | 2009 | 704 | 0.020 |
Why?
|
| Cerebral Ventricles | 2 | 1997 | 544 | 0.020 |
Why?
|
| Achievement | 1 | 2006 | 291 | 0.020 |
Why?
|
| Leptin | 1 | 2012 | 1593 | 0.020 |
Why?
|
| Mathematics | 1 | 1985 | 727 | 0.010 |
Why?
|
| Premature Birth | 1 | 2015 | 1713 | 0.010 |
Why?
|
| Matched-Pair Analysis | 1 | 2004 | 288 | 0.010 |
Why?
|
| Deinstitutionalization | 1 | 1983 | 21 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2012 | 3504 | 0.010 |
Why?
|
| Genetic Load | 1 | 2003 | 15 | 0.010 |
Why?
|
| Length of Stay | 2 | 1988 | 6294 | 0.010 |
Why?
|
| Self Report | 1 | 2014 | 3548 | 0.010 |
Why?
|
| Alcoholism | 1 | 1993 | 1904 | 0.010 |
Why?
|
| Suicide | 1 | 1993 | 1475 | 0.010 |
Why?
|
| Genotype | 1 | 2017 | 12946 | 0.010 |
Why?
|
| Recurrence | 1 | 2014 | 8333 | 0.010 |
Why?
|
| Gene Expression | 1 | 1995 | 7790 | 0.010 |
Why?
|
| Anxiety Disorders | 1 | 1993 | 2684 | 0.010 |
Why?
|
| Hyperprolactinemia | 1 | 2002 | 129 | 0.010 |
Why?
|
| Menstruation Disturbances | 1 | 2002 | 148 | 0.010 |
Why?
|
| Sensitivity and Specificity | 2 | 2010 | 14720 | 0.010 |
Why?
|
| Pyrazoles | 1 | 2011 | 1970 | 0.010 |
Why?
|
| Demography | 1 | 2006 | 1650 | 0.010 |
Why?
|
| Residence Characteristics | 1 | 1990 | 2049 | 0.010 |
Why?
|
| Body Height | 1 | 2006 | 1574 | 0.010 |
Why?
|
| Calcium | 1 | 2012 | 5753 | 0.010 |
Why?
|
| Maternal Welfare | 1 | 2000 | 115 | 0.010 |
Why?
|
| Radiography | 2 | 2004 | 7010 | 0.010 |
Why?
|
| Image Enhancement | 1 | 2010 | 2921 | 0.010 |
Why?
|
| Geniculate Bodies | 1 | 1980 | 163 | 0.010 |
Why?
|
| Signal Detection, Psychological | 1 | 1998 | 85 | 0.010 |
Why?
|
| Cats | 1 | 1980 | 998 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 1997 | 3862 | 0.010 |
Why?
|
| Personality Tests | 1 | 1997 | 83 | 0.010 |
Why?
|
| Apoptosis | 1 | 2014 | 9715 | 0.010 |
Why?
|
| Interviews as Topic | 1 | 2004 | 2536 | 0.010 |
Why?
|
| Massachusetts | 1 | 1990 | 8662 | 0.010 |
Why?
|
| Wechsler Scales | 1 | 1997 | 260 | 0.010 |
Why?
|
| Stereotyped Behavior | 1 | 1977 | 136 | 0.010 |
Why?
|
| Dextroamphetamine | 1 | 1977 | 129 | 0.010 |
Why?
|
| Neural Inhibition | 1 | 1980 | 598 | 0.010 |
Why?
|
| Dyskinesia, Drug-Induced | 1 | 1996 | 164 | 0.010 |
Why?
|
| Models, Neurological | 1 | 2004 | 1771 | 0.010 |
Why?
|
| Conditioning, Operant | 1 | 1977 | 313 | 0.010 |
Why?
|
| ROC Curve | 1 | 2003 | 3528 | 0.010 |
Why?
|
| Likelihood Functions | 1 | 1998 | 1003 | 0.010 |
Why?
|
| Reading | 1 | 1998 | 557 | 0.010 |
Why?
|
| Patient Compliance | 1 | 1985 | 2680 | 0.010 |
Why?
|
| Pregnancy Outcome | 1 | 2004 | 2795 | 0.010 |
Why?
|
| Evoked Potentials | 1 | 1980 | 1057 | 0.010 |
Why?
|
| Tic Disorders | 1 | 1994 | 127 | 0.010 |
Why?
|
| Data Collection | 1 | 2003 | 3339 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2009 | 7901 | 0.010 |
Why?
|
| Models, Theoretical | 1 | 1985 | 3584 | 0.010 |
Why?
|
| Ataxia | 1 | 1994 | 304 | 0.010 |
Why?
|
| Species Specificity | 1 | 1977 | 2479 | 0.010 |
Why?
|
| Patient Discharge | 1 | 1985 | 3300 | 0.010 |
Why?
|
| Reaction Time | 1 | 1998 | 2092 | 0.010 |
Why?
|
| Obstetric Labor Complications | 1 | 1994 | 238 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2010 | 18006 | 0.010 |
Why?
|
| Hospitalization | 1 | 1990 | 10232 | 0.010 |
Why?
|
| Artificial Intelligence | 1 | 2004 | 2187 | 0.010 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 1994 | 657 | 0.010 |
Why?
|
| Germany, West | 1 | 1989 | 13 | 0.010 |
Why?
|
| Antigens | 1 | 1994 | 1462 | 0.010 |
Why?
|
| Binding Sites | 1 | 1997 | 6115 | 0.000 |
Why?
|
| Blotting, Western | 1 | 1994 | 5180 | 0.000 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2003 | 9941 | 0.000 |
Why?
|
| Models, Genetic | 1 | 1996 | 3493 | 0.000 |
Why?
|
| Brain Diseases | 1 | 1994 | 1554 | 0.000 |
Why?
|
| Histones | 1 | 1994 | 2597 | 0.000 |
Why?
|
| Immunohistochemistry | 1 | 1997 | 11363 | 0.000 |
Why?
|
| Databases, Factual | 1 | 1998 | 7716 | 0.000 |
Why?
|
| Brain Injuries | 1 | 1994 | 2024 | 0.000 |
Why?
|
| Nerve Tissue Proteins | 1 | 1994 | 4465 | 0.000 |
Why?
|